World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Autoimmune Diseases
The Power of Vendor–Laboratory Partnerships
Miriam Bergeret, MSc
Geisinger Medical Center’s immunology laboratory recently maximized their workflows through a vital partnership with Thermo Fisher Scientific
Novel Model Could Make IBD Tests Less Invasive
American Chemical Society
Glycosylation on antibodies may accurately detect and differentiate Crohn’s and ulcerative colitis
FDA Approves First Biosimilar to Treat Multiple Sclerosis
U.S. Food and Drug Administration
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
Immune Repertoire Sequencing May Be Coming to a Lab Near You
Bradley W. Langhorst, PhD, Chen Song, PhD
The rapidly evolving field of immune sequencing is poised to have a wide-ranging impact to clinical practice
FDA Approves First Cellular Therapy for Type 1 Diabetes
U.S. Food and Drug Administration
Clinicians should consider the adverse effects when recommending Lantidra to patients
Genetic Markers Exacerbating MS Severity Identified
University of Cambridge
Discovery opens the door to treatments for multiple sclerosis-associated long-term disability
Pediatric Crohn’s Disease Clinical Trial Yields Game-Changing Outcomes
University of North Carolina School of Medicine
Findings revealed the efficacy of anti-TNF inhibitors monotherapy versus combination therapy with anti-TNF inhibitors and immunosuppressants
Experts Recommend Genetic Testing to Prevent Fatal Brain Infection
Emerald Lake Safety
MS and PML experts argue that preventive screening should become the new standard of care
Of Mice and Men: Humanized Mouse Models Provide Powerful Immune System Insights
TransCure bioServices
CD34+ mouse models that better recapitulate the human immune system in mice could help advance drug development